Related Experiment Video
Updated: Jun 30, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Digital tools and biomarkers for cognitive screening: A systematic review
Seunghui Hong1, ChanHee Kim2, Seon Heui Lee3
1Department of Nursing, Graduate School, Gachon University, Incheon, Republic of Korea.
Digital Health
|June 29, 2026
Summary
Digital cognitive assessment tools show promise for early detection of cognitive impairment. Tailoring tool selection and integrating digital biomarkers can enhance community-based nursing care, but real-world validation is needed.
Area of Science:
- Gerontology
- Digital Health
- Cognitive Science
Background:
- Cognitive impairment affects a growing older adult population.
- Early detection and continuous monitoring are crucial for managing cognitive decline.
- Digital tools offer novel approaches to cognitive assessment.
Purpose of the Study:
- To systematically review and compare digitized traditional tests, new digital tools, and digital biomarkers for cognitive assessment.
- To evaluate their validity, feasibility, and potential for integration into community-based healthcare.
- To explore clinical utility and implementation challenges of digital cognitive assessment.
Main Methods:
- Systematic review following PRISMA guidelines, searching nine electronic databases.
- Inclusion of 48 studies on digital cognitive assessment tools or biomarkers in older adults.
- Narrative synthesis of data and extraction of diagnostic accuracy metrics (sensitivity, specificity, AUC).
Main Results:
- Digital cognitive tools demonstrated promising diagnostic accuracy across categories: digitized traditional tests (AUC: 0.65-1.0), new digital tools (AUC: 0.75-0.94), and digital biomarkers (AUC: 0.59-0.95).
- Most studies were conducted in controlled settings with limited real-world validation.
- Potential for community-based implementation exists, particularly with self-administered and remote assessments, though evidence for healthcare professionals is limited.
Conclusions:
- Digital cognitive assessments and biomarkers can enhance early screening and monitoring of cognitive impairment.
- Tool selection should be context-specific, with digital biomarkers complementing assessments in community nursing.
- Guidelines are needed for the safe and effective adoption of digital cognitive tools in healthcare settings.
